Kerydin

Kerydin is a brand name for a topical medication containing the active ingredient tavaborole. Tavaborole is an antifungal medication used to treat onychomycosis, a fungal infection of the toenails. It works by inhibiting an enzyme called methionyl-tRNA synthetase, which is essential for fungal protein synthesis. By disrupting this process, tavaborole effectively stops the growth and spread of the fungi causing the infection.

Kerydin is applied directly to the affected toenails and surrounding skin once a day. The medication is designed to penetrate the nail plate to reach the site of infection. Treatment duration typically varies depending on the severity of the infection, but often lasts for several months. It is important to follow the prescribing doctor's instructions carefully and to complete the full course of treatment to ensure the infection is cleared.

Common side effects associated with Kerydin use can include redness, itching, and inflammation in the area of application. In some cases, ingrown toenails or blistering may also occur. It is advisable to inform a healthcare professional of any adverse reactions experienced during treatment. Kerydin is generally not recommended for use in individuals with known hypersensitivity to tavaborole or any of the inactive ingredients in the formulation.